Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04477460 · ClinicalTrials.gov registry record

Effect of Thickened Feeds on Clinical Outcomes in Children With Brief Resolved Unexplained Event

A clinical trial of Oropharyngeal Dysphagia and Brief Resolved Unexplained Event, sponsored by Boston Children's Hospital.

Recruiting
Registry status
250
Enrollment target
1
Study location

NCT04477460 is a study of Oropharyngeal Dysphagia and Brief Resolved Unexplained Event that is actively recruiting participants, run by Boston Children's Hospital. The registered enrollment target is 250 participants, above the 75-participant average among 7 other Oropharyngeal Dysphagia trials with a reported enrollment target (233% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04477460, a study of Oropharyngeal Dysphagia and Brief Resolved Unexplained Event, is actively recruiting participants, sponsored by Boston Children's Hospital.

RECRUITING
Registry status
250 participants
Enrollment target
1
Study location

Study Summary

This observational study will examine the effects of thickened feeds on clinical outcomes and healthcare utilization in infants with brief resolved unexplained event (BRUE).

Interventions

  • DIETARY_SUPPLEMENT Thickened feeds
  • DIETARY_SUPPLEMENT Non-thickened feeds

Study Locations (1)

Massachusetts

  • Boston Children's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2021-04-01
Est. Completion 2026-08-31

Sponsor

Boston Children's Hospital

462 total trials

What the Registry Record Tells You About NCT04477460

The ClinicalTrials.gov registry entry for NCT04477460 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 75-participant average among 7 other Oropharyngeal Dysphagia trials with a reported enrollment target (233% higher). The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Oropharyngeal Dysphagia appearing as the primary indexed condition, and to 2 interventions - of which Thickened feeds is the first listed.

NCT04477460 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT04477460 about?

NCT04477460 is a clinical study titled "Effect of Thickened Feeds on Clinical Outcomes in Children With Brief Resolved Unexplained Event". This observational study will examine the effects of thickened feeds on clinical outcomes and healthcare utilization in infants with brief resolved unexplained event (BRUE).

What is the current status of trial NCT04477460?

This trial is currently recruiting. The enrollment target is 250 participants. The study started on 2021-04-01. Estimated completion is 2026-08-31.

What conditions does trial NCT04477460 study?

This clinical trial studies the following conditions: Oropharyngeal Dysphagia, Brief Resolved Unexplained Event, Apparent Life Threatening Event.

What interventions are being tested in trial NCT04477460?

The interventions under investigation include: Thickened feeds (DIETARY_SUPPLEMENT), Non-thickened feeds (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT04477460?

This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04477460 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Oropharyngeal Dysphagia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.